THE charity Crohn's Colitis Cure (CCCure) is leading a global coalition of consumer and clinician groups to develop a solution for inflammatory bowel disease (IBD).
The Australian initiative aims to provide personalised care, enhancing patient control over their health data and improving the quality of clinician consultations.
CCCure's new cloud-based consumer app integrates patient-reported data with clinical records, offering tailored information on nutrition, medications, side effects, and access to trials.
The approach empowers patients, and helps clinicians access reliable data, addressing the need for more personalised IBD care.
The app's de-identified clinical data will also be available to third parties for research, treatment development, and regulatory submissions, potentially advancing the search for a cure for the disease.
Crohn's & Colitis organisations in Australia, USA, UK and New Zealand, and the Gastroenterological Nurses College of Australia are backing the innovative solution, supporting its development and adoption globally.
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Sep 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Sep 24
